Kliniken Maria Hilf GmbH

Mechanical thrombectomy for acute ischemic stroke in COVID-19 patients: multicenter experience in 111 cases (2022) Styczen H, Maus V, Goertz L, Koehrmann M, Kleinschnitz C, Fischer S, Moehlenbruch M, et al. Journal article Seronegative myasthenic crisis: a multicenter analysis (2022) Mergenthaler P, Stetefeld HR, Dohmen C, Kohler S, Schoenenberger S, Boesel J, Gerner S, et al. Journal article A pre-infection laboratory score identifies cancer patients at risk for severe COVID-19: an analysis of the ADHOK coronavirus tumor registry (2021) Roesch R, Suedhoff T, Wendtner CM, Kullmann F, Schaich M, Kubin T, Mueller-Naendrup C, et al. Conference contribution ELDORANDO - Pembrolizumab compared with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115) (2021) Klinghammer K, Graeven U, Ivanyi P, Dietz A, Hahn D, Hackenberg S, Kasper S, et al. Conference contribution Idiopathic granulomatous interstitial nephritis and isolated renal sarcoidosis: Two diagnoses of exclusion (2021) Janssen U, Naderi S, Amann KU Journal article, Review article Fireside chat § 13 (2b) AMG in nuclear medicine therapy - A follow-up event of NuklearMedizin 2020 - Digital Kamingespräch § 13 (2b) AMG in der nuklearmedizinischen Therapie - eine Follow-up-Veranstaltung der NuklearMedizin 2020 - Digital (2021) Patt M, Bengel F, Essler M, Krause BJ, Kuwert T, Rahbar K, Sabri O, et al. Journal article Role and benefits of infectious diseases (ID) specialists in the COVID-19 pandemics (2021) Tscharntke L, Jung N, Rieg S, Spinner C, Hanses F, Borgmann S, Wille K, et al. Conference contribution Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial (2021) Kosmala R, Fokas E, Flentje M, Sauer R, Liersch T, Graeven U, Fietkau R, et al. Journal article Results of a randomized phase II study comparing pembrolizumab with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115) (2021) Gruenwald V, Graeven U, Ivanyi P, Dietz A, Hahn D, Hackenberg S, Kasper S, et al. Conference contribution MuSK-antibodies are associated with worse outcome in myasthenic crisis requiring mechanical ventilation (2021) Konig N, Stetefeld HR, Dohmen C, Mergenthaler P, Kohler S, Schonenberger S, Bosel J, et al. Journal article